Clinical Trials Browser

INDUSTRY × MEDI2070 × Clear all

NCT01714726 2021-05-26

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

Phase 2 Completed

121 enrolled 22 charts

Crohn Disease, Inflammatory Bowel Diseases

NCT02574637 2021-05-26

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Phase 2 Terminated

29 enrolled 25 charts

Crohn Disease, Inflammatory Bowel Diseases